Berzosertib

Berzosertib
Item number Size Datasheet Manual SDS Delivery time Quantity Price
TGM-T2669-1mg 1 mg

7 - 10 business days*

31.00€
TGM-T2669-5mg 5 mg

7 - 10 business days*

67.00€
TGM-T2669-1mL 1 ml

7 - 10 business days*

71.00€
TGM-T2669-10mg 10 mg

7 - 10 business days*

93.00€
TGM-T2669-25mg 25 mg

7 - 10 business days*

156.00€
TGM-T2669-50mg 50 mg

7 - 10 business days*

236.00€
TGM-T2669-100mg 100 mg

7 - 10 business days*

376.00€
TGM-T2669-200mg 200 mg

7 - 10 business days*

552.00€
TGM-T2669-500mg 500 mg

7 - 10 business days*

877.00€
 
Description: Berzosertib (VE-822) is an ATR inhibitor (Ki<0.2 nM) that also inhibits ATM (Ki=34... more
Product information "Berzosertib"
Description: Berzosertib (VE-822) is an ATR inhibitor (Ki<0.2 nM) that also inhibits ATM (Ki=34 nM). Berzosertib has antitumor activity and has been used in trials investigating the treatment of ovarian tumors, plasmacytoid tumors of the ovary, solid tumors in adults, advanced solid tumors, and advanced solid tumors. Target: ATM/ATR. Smiles: CNCc1ccc(cc1)-c1cc(on1)-c1nc(cnc1N)-c1ccc(cc1)S(=O)(=O)C(C)C. References: Fokas E, et al. Cell Death Dis, 2012, 3, e441.
Keywords: VE-822, VX-970
Supplier: TargetMol
Supplier-Nr: T2669

Properties

Application: Targets serine/threonine-protein kinase ATR [EC:2.7.11.1] (ATR)
MW: 463.55 D
Formula: C24H25N5O3S

Database Information

CAS : 1232416-25-9| Matching products
KEGG ID : K06640 | Matching products

Handling & Safety

Storage: -20°C
Shipping: +4°C (International: +4°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "Berzosertib"
Write a review
or to review a product.
Viewed